LabCorp Venture Fund Portfolio

Adaptive Biotechnologies is a leader in immune-driven medicine that aims to improve people’s lives by translating our adaptive immune systems with unprecedented scale and precision and applying these insights to develop products that will transform the way diseases are diagnosed and treated.

Advanced Animal Diagnostics utilizes rapid point-of-care diagnostic information systems to reduce the reliance on antibiotics in livestock.

Aetion is a healthcare technology company that delivers real-world evidence for life sciences, payers, providers, and regulatory agencies. Aetion informs health care’s most critical decisions to guide treatment development, commercialization, and payment innovation into health care’s modern era.

Ativa’s mission is to reduce cost and improve the accessibility of primary care by transforming a major rate-limiting step – immediate access to diagnostic test results.

Boston Microfluidics specializes in simple sampling with accurate results, making it easy to connect you to your health.

Emulate’s Human Emulation System sets a new standard for recreating true-to-life human biology and is being used to advance product innovation, design, and safety across a range of applications, including drug development, agriculture, cosmetics, food, and chemical-based consumer products.

Epic Sciences, Inc. is developing novel diagnostics to personalize and advance the treatment and management of cancer through our liquid biopsy platform, which characterizes rare cells, including circulating tumor cells.

Fabric Genomics is making genomics-driven precision medicine a reality by providing AI-based clinical-decision support software that enable clinical labs and hospital systems to make significantly faster and more accurate diagnoses.

Flatiron Health is a healthcare technology and services company focused on accelerating cancer research and improving patient care. Our platform enables cancer researchers and care providers to learn from the experience of every patient.

GeneCentric parses complex tumor biology into genomic signatures, revealing high-resolution cancer subtypes to identify drug responder populations and help target both new and established cancer therapeutics.

Kiyatec accurately models and predicts cancer patient response to drug therapies, using 3D cell culture technology, to inform clinical decision making and drive drug development.

MC10's mission is to improve human health through digital healthcare solutions. MC10 commercializes novel sensors and software for remote data capture, analysis, and insights in clinical trial and patient management applications. 

Mission Bio provides a precision genomics platform, powered by proprietary droplet microfluidics, to accelerate the discovery, development, and delivery of precision medicine.

Navigating Cancer is the leading Patient Relationship Management technology and solutions company focused on improving the patient experience, delivering more effective care management, and enabling oncology care innovation. With over 1,700 providers adopting the Navigating Care platform, it is the most deployed patient management solution in oncology. 

OneOme is an innovator in precision medicine and pharmacogenetics. OneOme strives to empower smarter prescription decisions through its RightMed® test and medication optimization platform.

PathAI is a leading provider of AI-powered research tools and services for pathology. PathAI’s platform promises substantial improvements to the accuracy of diagnosis and the efficacy of treatment of diseases like cancer, leveraging modern approaches in machine and deep learning.

Precision Digital Health (PDH) is a Software-as-a-Service (SaaS) platform company that specializes in the use of real-world data (RWD) to generate real-world evidence (RWE) in support of clinical research, drug development, and to improve health-related outcomes. 

Sandstone’s mission is to make high quality medical testing ubiquitous by bringing powerful, portable CentriFluidic™ Technology to the point of care.

Serimmune reveals the many diverse antigens that stimulate the human immune system - enabling unlimited multiplexing of antibody serology tests from a single assay and specimen, and accelerating the discovery and development of immuno-therapeutics.  

Seventh Sense Biosystems has designed and developed TAP™, the world’s first push-button blood collection device that makes the process simple, convenient, and virtually painless.

Talis is transforming medical care by enabling time-critical molecular diagnostic results where and when clinical decisions are made.

The Recovery Platform is an opioid treatment platform focused on retention and reduced relapse for Medication Assisted Treatment patients. The platform is seamlessly integrated with laboratories, state PDMPs, and EHRs and leverages state of the art technology, including concierge services such as telemedicine.

Vivify Health is transforming healthcare with the market’s most comprehensive, patient-centered, connected care platform, with a focus on greater engagement and adherence for better clinical and financial outcomes.